Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CAVA Group, Inc.(CAVA) | 9,507,990 | 9,507,990 | 0 | $1.07B | $821.59M | 92.92% | -$250.92M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 136,180,481 | 136,180,481 | 0 | $100.77M | $62.64M | 7.08% | -$38.13M |